US Disposable Syringe Market to Cross $ 18 Billion by 2021: Pharmaion Consultants Report

BURNABY, Canada, February 15, 2016 /PRNewswire/ --

Growing awareness about cross-contamination and rising incidence of accidental needlestick injuries, coupled with effective implementation of government regulations to drive United States disposable syringe market through 2021

According to Pharmaion report, "United States Disposable Syringe Market Opportunities, 2011 - 2021", the disposable syringe market in the United States is projected to cross US$ 18 billion by 2021. Some of the major factors boosting the demand for disposable syringes in the United States include increasing technological advancements, growing awareness about various infections from blood-borne pathogens and rising incidence of accidental needlestick injuries. Moreover, owing to the country's increasing disease burden and presence of a large number of hospitals, demand for disposable syringes in the US is projected to grow over the next five years.

Healthcare workers, such as physicians, nursing staff and laboratory staff, are at high risk of accidental needlestick injuries. It has been observed that the most frequent cause of sharp injuries in different healthcare set-ups in the United States is syringes, followed by IV catheter stylet and butterfly needle. Disposable syringes market in the US has significantly benefited from the implementation of US Needle Stick Safety and Prevention Act of 2000, which advocates usage of safer medical devices to eliminate or minimize exposure to pathogens from needlestick injuries.

United States disposable syringe market has been segmented into two categories, namely, conventional syringes and safety syringes. Out of these two categories, conventional syringes dominated the overall disposable syringe market in the United States in 2015. The segment is anticipated to continue its dominance through 2021 on account of low prices of conventional syringes coupled with their effectiveness in mitigating the spread of blood borne infections and diseases. However, in terms of growth, safety syringe segment is projected to outpace conventional syringe segment during 2016 - 2021.

"United States disposable syringe market is expected to continue exhibiting promising growth over the next five years. Innovations and new product launches by the existing market players and new entrants is the major factor, which is anticipated to drive the disposable syringe market of the United States during forecast period. Moreover, growing adoption of Pre-Filled Safety Syringes (PFS), Disposable Dental Syringes, Needle-Free Injectors and Auto-Retractable Safety Syringes is expected to have a positive influence on the country's disposable syringe market, going forward." said Mr. Brijesh Khurana, Research Manager with Pharmaion, a research based global management consulting firm focused on pharma and healthcare industry.

"United States Disposable Syringe Market Opportunities, 2011 - 2021" has analyzed the potential of disposable syringe market in the United States and provides statistics and information on market sizes, shares and trends. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyzes the emerging trends along with essential drivers and key challenges faced in the United States disposable syringe market.

About Pharmaion 

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion's clients lead rather than follow market trends. Pharmaion has developed a proprietary database which focuses on identifying the unexplored opportunities in Healthcare and Pharmaceutical industry.

Media Contact
Karan Chechi
Research Director
Contact Phone- +1 646 862 0089
Email- [email protected]

SOURCE Pharmaion Consultants